Literature DB >> 28718703

Nanoliposome improves inhibitory effects of naringenin on nonalcoholic fatty liver disease in mice.

Cong Chen1, Xu Jie2, Yangjie Ou1, Yini Cao1, Lu Xu1, Yunxia Wang1, Rong Qi1.   

Abstract

Aim: To prepare naringenin nanoliposome (NRG-Nanolipo) and investigate its inhibitory effects on nonalcoholic fatty liver disease (NAFLD). Materials & methods: NRG-Nanolipo was prepared by thin-film rehydration method. Its characterizations and effects on NAFLD in mice induced by methionine choline deficient diet were investigated.
Results: NRG-Nanolipo had high-drug loading percentage and showed a sustained release profile. The nanoliposome formulation significantly increased oral absorption of naringenin (NRG). NRG-Nanolipo showed comparable inhibitory effects as NRG crude drug at a dose fourfold lower than the crude drug on NAFLD.
Conclusion: It is the first study to report the inhibitory effects of NRG on NAFLD, and the NRG-Nanolipo significantly improved oral absorption of NRG, thus improved liver protective effects of NRG on NAFLD.

Entities:  

Keywords:  nanoliposome; naringenin; nonalcoholic fatty liver disease

Year:  2017        PMID: 28718703     DOI: 10.2217/nnm-2017-0119

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  5 in total

1.  Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3/NF-κB pathway in mice.

Authors:  Qinyu Wang; Yangjie Ou; Guomin Hu; Cong Wen; Shanshan Yue; Cong Chen; Lu Xu; Jiawei Xie; Hui Dai; Han Xiao; Youyi Zhang; Rong Qi
Journal:  Br J Pharmacol       Date:  2020-01-30       Impact factor: 8.739

2.  Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial.

Authors:  Fatemeh Naeini; Zahra Namkhah; Helda Tutunchi; Seyed Mahdi Rezayat; Siavash Mansouri; Seyed Ali Jazayeri-Tehrani; Mehdi Yaseri; Mohammad Javad Hosseinzadeh-Attar
Journal:  Trials       Date:  2021-11-13       Impact factor: 2.279

3.  Enhanced Antioxidant Effects of Naringenin Nanoparticles Synthesized using the High-Energy Ball Milling Method.

Authors:  Anas Ahmad; Ravi Prakash; Mohd Shahnawaz Khan; Nojood Altwaijry; Muhammad Nadeem Asghar; Syed Shadab Raza; Rehan Khan
Journal:  ACS Omega       Date:  2022-09-19

4.  A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease.

Authors:  Fatemeh Naeini; Zahra Namkhah; Alireza Ostadrahimi; Helda Tutunchi; Mohammad Javad Hosseinzadeh-Attar
Journal:  Adv Nutr       Date:  2021-03-31       Impact factor: 8.701

Review 5.  The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update.

Authors:  Reem Abou Assi; Ibrahim M Abdulbaqi; Chan Siok Yee
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.